Clinical outcomes of adult patients with primary intracranial germinomas treated with low-dose craniospinal radiotherapy and local boost.

Abstract

The authors document the long term follow up of adult patients with histologically proven primary intracranial germinoma treated with radiotherapy alone using a craniospinal with local boost technique. A retrospective review was conducted on adults diagnosed with intracranial germinoma who received radiotherapy at the Princess Margaret Hospital, Toronto from 1990 to 2007. The study group consisted of 10 males with a median age of 24.1 years. All patients received radiotherapy alone using craniospinal radiotherapy and local boost. There were 10 patients (all male) with a median follow up of 10.9 years (range 2.2-18.9 years). At date of last follow up all patients were still alive, none with relapsed disease. Seven of ten patients (70%) had panhypopituitarianism prior to commencing radiotherapy and hormonal function was not affected in those with an intact pituitary axis. There was no reported cognitive decline in the treated cohort. For adult intracranial germinomas, with long term follow up, low-dose craniospinal radiotherapy with in field boost is highly effective with minimal morbidity.

• Authors: M Foote, B-A Millar, A Sahgal, C Ménard, D Payne, W Mason, N Laperriere
• Journal: Journal of neuro-oncology (J Neurooncol) Vol. 100 Issue 3 Pg. 459-63 (Dec 2010) ISSN: 1573-7373 [Electronic] United States
• PMID: 20455001 (Publication Type: Journal Article)

Topics

• Adolescent
• Adult
• Brain Neoplasms (radiotherapy)
• Cognition Disorders (etiology)
• Disease-Free Survival
• Endocrine System (radiation effects)
• Germinoma (radiotherapy)
• Humans
• Magnetic Resonance Imaging (methods)
• Male
• Radiosurgery (adverse effects)
• Radiotherapy Dosage
• Retrospective Studies
• Tomography Scanners, X-Ray Computed
• Treatment Outcome
• Young Adult